Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shin Poong PharmCo Ltd (019170) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3488
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shin Poong PharmCo Ltd (Shin Poong) is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company provides drugs such as psychoneurotic, anti-cancer, cardiovascular, antihistamine, antirheumatic and benign prostatic hyperplasia drugs, among others. It also provides antibiotics, antifungal and antiviral agents, antiulcerants, anti-diabetics, and trichogens. Shin Poong offers cardiovascular, anti-diabetic, NSAIDs, anti-biotic, propulsive, anti-ulcer, anti-arthritis, anti-spasmodic, respiratory, anti-cancer, and anti-helminthic APIs, among others. The company also provides chemotherapeutics, contraceptive agents, and other products. It has its operations through its production facilities located in Gyeonggi-do and Chungcheongbuk-do, South Korea. Shin Poong is headquartered in Seoul, South Korea.

Shin Poong PharmCo Ltd (019170) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shin Poong PharmCo Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Shin Poong Pharma Forms Joint Venture With Laboratoire Francais De Fractionnement 11
Licensing Agreements 13
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 13
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 14
Equity Offering 15
Shin Pooong Pharm to Raise USD34.5 Million in Private Placement of Shares 15
Shin Poong PharmCo Ltd – Key Competitors 16
Shin Poong PharmCo Ltd – Key Employees 17
Shin Poong PharmCo Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shin Poong PharmCo Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Shin Poong PharmCo Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shin Poong Pharma Forms Joint Venture With Laboratoire Francais De Fractionnement 11
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 13
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 14
Shin Pooong Pharm to Raise USD34.5 Million in Private Placement of Shares 15
Shin Poong PharmCo Ltd, Key Competitors 16
Shin Poong PharmCo Ltd, Key Employees 17
Shin Poong PharmCo Ltd, Other Locations 18
Shin Poong PharmCo Ltd, Subsidiaries 18

List of Figures
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shin Poong PharmCo Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PTB Group Limited:企業の戦略・SWOT・財務情報
    PTB Group Limited - Strategy, SWOT and Corporate Finance Report Summary PTB Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Colt Technology Services Group Ltd:企業の戦略的SWOT分析
    Colt Technology Services Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Regenicin Inc (RGIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tiss …
  • RHÖN-KLINIKUM AG:企業の戦略・SWOT・財務情報
    RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report Summary RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kadmon Corp LLC-製薬・医療分野:企業M&A・提携分析
    Summary Kadmon Corp LLC (Kadmon) is a biopharmaceutical company that offers products and related services for the management and treatment of hepatitis C. The company also develops therapies for metabolic and serious diseases. Its products include ribavirin, USP Tablets, ribavirin capsules, phenterm …
  • Tower International Inc (TOWR):企業の財務・戦略的SWOT分析
    Tower International Inc (TOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Penn United Technologies, Inc.:企業の戦略・SWOT・財務情報
    Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Egdon Resources Plc (EDR):石油・ガス:M&Aディール及び事業提携情報
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • Shinhan Financial Group Co Ltd:戦略・SWOT・企業財務分析
    Shinhan Financial Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shinhan Financial Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Accelerate Resources Ltd (AX8):企業の財務・戦略的SWOT分析
    Accelerate Resources Ltd (AX8) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Transat A.T. Inc:企業の戦略・SWOT・財務分析
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Korea Midland Power Co Ltd:企業の戦略的SWOT分析
    Korea Midland Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Moog Inc (MOG.A):企業の財務・戦略的SWOT分析
    Moog Inc (MOG.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hycrete Inc:企業の戦略的SWOT分析
    Hycrete Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Giant Eagle, Inc.:戦略・SWOT・企業財務分析
    Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report Summary Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Checkpoint Therapeutics Inc (CKPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Checkpoint Therapeutics Inc (Checkpoint Therapeutics), a subsidiary of Fortress Biotech Inc, is a clinical-stage biopharmaceutical company that acquires, develops and commercializes non-chemotherapy and immune enhanced combination treatments for the treatment of solid tumor cancers. The comp …
  • Hanwha Q CELLS Co Ltd (HQCL):電力:M&Aディール及び事業提携情報
    Summary Hanwha Q CELLS Co Ltd (Q CELLS) is a vertically integrated solar solution provider. It develops, manufactures and sells solar cells and modules. The company produces a wide range of PV cells and modules, and silicon ingots; and provides EPC services for the development and installation of gr …
  • Nolato AB (NOLA B):企業の財務・戦略的SWOT分析
    Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • EnergySolutions, Inc.:企業の戦略・SWOT・財務情報
    EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • GeoPark Ltd (GPRK):石油・ガス:M&Aディール及び事業提携情報
    Summary GeoPark Ltd (GeoPark) is an oil and gas exploration and production company that explores, develops and produces upstream oil and gas in Latin America. The company operates various blocks such as Colombia blocks, Chile blocks, Brazil blocks, Peru blocks and Argentina blocks. Its Colombia bloc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆